/
/
Π Vivo ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π°Π½ΡΠΈΠΌΠΈΠΊΡΠΎΠ±Π½ΠΎΠΉ Π‘ΠΈΠ½ΡΡ Π‘Π²Π΅ΡΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π΄Π»Ρ ΠΠΎΠ»ΠΈΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ Acinetobacter baumannii ΠΠΆΠΎΠ³ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ Π±ΠΈΠΎΠ»ΡΠΌΠΈΠ½Π΅ΡΡΠ΅Π½ΡΠΈΠΈ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ
Γ necessario avere un abbonamento a JoVE per visualizzare questo. Accedi o inizia la tua prova gratuita.
1Wellman Center for Photomedicine,Massachusetts General Hospital, Harvard Medical School, 2Department of Medical Oncology,Beijing Institute of Translational Medicine, Chinese Academy of Sciences, 3Cancer Center, Aviation General Hospital, Beijing, 4Infectious Disease Service,Brooke Army Medical Center
Capitoli
- 00:05Titolo
- 01:38Mouse Model of Burn Infection Caused by Bioluminescent A. baumannii
- 03:04Bioluminescence Imaging of Infections in Mice
- 04:27Antimicrobial Blue Light Therapy for A. baumannii Infection in Mice
- 06:51Results: Antimicrobial Blue Light Therapy for A. baumannii Burn Infections
- 08:21Conclusion
Infections caused by multidrug-resistant (MDR) bacterial strains have emerged as a serious threat to public health, necessitating the development of alternative therapeutics. We present a protocol to evaluate the effectiveness of antimicrobial blue light (aBL) therapy for MDR Acinetobacter baumannii infections in mouse burns by using bioluminescence imaging.
